Summarizes the state of the art in the management of locally advanced and metastatic prostate cancer Evaluates the role of abiraterone and enzalutamide, docetaxel-based chemotherapy, and novel agents Discusses surgical approaches and the role of adjuvant and neoadjuvant therapy Examines current radiotherapy techniques This textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer to provide the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and variou
One-stop Solution is now just one click away.
All it takes is 30 seconds to Download.
Download Katib App Now!
- Choosing a selection results in a full page refresh.
- Press the space key then arrow keys to make a selection.
- Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device